Dr. Khetisuda Suvarnasuddhi, MD

Dr. Suvarnasuddhi practices at Eastern Boulevard Dialysis in Hagerstown, Maryland.

Dr. Suvarnasuddhi's NPI, 1083059455, was assigned on April 30, 2013. Dr. Suvarnasuddhi holds Maryland license D0085666.

Dr. Suvarnasuddhi's primary practice is Eastern Boulevard Dialysis, at 12931 Oak Hill Ave, Hagerstown, MD 21742 in Washington County. The practice phone is (301) 745-4251.

Dr. Suvarnasuddhi's primary practice is Eastern Boulevard Dialysis in Hagerstown, Maryland. Dr. Suvarnasuddhi is also affiliated with Meritus Medical Center. The medical group on file is Meadow Kidney Care. Dmand AI also links Dr. Suvarnasuddhi to 4 more hospitals, 4 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Suvarnasuddhi practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Suvarnasuddhi's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Suvarnasuddhi's licenses on file in 2 states: Maryland and Rhode Island.

CMS data shows 2,623 Medicare services from Dr. Suvarnasuddhi across 17 procedure codes in 2024, for 880 Medicare patients. Medicare paid $218,231 for them.

CMS counts 880 Medicare patients who saw Dr. Suvarnasuddhi in 2024. The largest group is 75 to 84, with 325 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 20% are also on Medicaid. Their average risk score is 2.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Suvarnasuddhi's median patient age at 71, with 51% women.

In 2024, Dr. Suvarnasuddhi wrote 1,585 Medicare Part D claims for 284 patients. 90% of them were for generic drugs. CMS names the drug for 1,367 of them, across 39 drugs with 11 or more claims each, at $239,530 in total drug cost. In 2023, CMS named 956 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 56 out of 100 for Dr. Suvarnasuddhi for performance year 2024, reported as part of a group. Dr. Suvarnasuddhi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Suvarnasuddhi as offering telehealth.

CMS Open Payments shows 153 general payments to Dr. Suvarnasuddhi from 28 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 99% of the total. Horizon Pharma plc paid the most, $460.